Pfizer, Eli Lilly Were The Original Medical Marijuana Sellers

An early American study has assessed the safety of a drug made from a compound derived from cannabis.

DISTRICT OF COLUMBIA:  Today’s major pharmaceutical companies were the original medical marijuana sellers. Eli Lilly, Parke-Davis (now owned by Pfizer) and Squibb of Bristol-Myers Squibb all sold medical marijuana at the turn of the century. In a 1919 medical catalog, these companies listed several cannabis products. Back then, most medicines were the same – the Read the full article…

Are There Any Marijuana Stocks To Buy In 2015?

NORML Top 10 Events of 2016

DISTRICT OF COLUMBIA:  Perhaps nothing caught the eyes of speculative investors more than marijuana stocks in 2014, but just because marijuana stocks put up significant returns last year doesn’t mean that they can do it again in 2015. We asked our Motley Fool contributors to share their thoughts on whether there are any marijuana stocks Read the full article…

Medical Marijuana Debate Focuses On What Is An Approved Drug, And Language Of Proposed Amendment

Opponents argue that medical marijuana isn’t needed because an FDA-controlled version is already available.

FLORIDA:  Voters will consider making Florida the 24th state and the first in the South to approve a comprehensive medical marijuana program, but opponents argue a synthetic form of marijuana already offers medical relief that’s controlled by the Food and Drug Administration. The debate over medical marijuana in Florida has raged between supporters who cast Read the full article…

Study: Most Patients Prefer Herbal Cannabis Over Marijuana-Based Pharmaceuticals

Cannabis smoking, closely followed by vaporizing, scored highest for satisfaction

NETHERLANDS: Subjects who consume cannabis for therapeutic purposes prefer herbal forms of the plant to pharmaceutically produced derivatives, according to survey data published in The Journal of Psychoactive Drugs. Investigators from Canada, Germany, the Netherlands, and the United States conducted a web-based survey consisting of 21 structured questions to assess patients’ perceptions of different types of cannabinoid-based medicinal products Read the full article…